Based on the key indicators related to Processa Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Processa Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At present, Processa Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 6.5 M, whereas Property Plant And Equipment Net is forecasted to decline to about 126.4 K. Key indicators impacting Processa Pharmaceuticals' financial strength include:
The essential information of the day-to-day investment outlook for Processa Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Processa Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Processa Pharmaceuticals.
Please note, the presentation of Processa Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Processa Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Processa Pharmaceuticals' management manipulating its earnings.
Processa Pharmaceuticals Stock Summary
Processa Pharmaceuticals competes with Acurx Pharmaceuticals, Fennec Pharmaceuticals, SAB Biotherapeutics, Third Harmonic, and Inhibrx. Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. The company was incorporated in 2011 and is based in Hanover, Maryland. Processa Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Processa Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Processa Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Processa Pharmaceuticals competition to find correlations between indicators driving Processa Pharmaceuticals's intrinsic value. More Info.
Processa Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Processa Pharmaceuticals' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Processa Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Processa Pharmaceuticals Systematic Risk
Processa Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Processa Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Processa Pharmaceuticals correlated with the market. If Beta is less than 0 Processa Pharmaceuticals generally moves in the opposite direction as compared to the market. If Processa Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Processa Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Processa Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Processa Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Processa Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Processa Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Processa Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.007703
At present, Processa Pharmaceuticals' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
Processa Pharmaceuticals February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Processa Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Processa Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Processa Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Processa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Processa Pharmaceuticals's daily price indicators and compare them against related drivers.
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.